Sanguine BioSciences Lands $5,534,250 New Financing Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=fdf107b5-ba1d-4191-9555-d27f7a4f4814
Date
11/26/2014
Company Name
Sanguine BioSciences
Mailing Address
15335 Morrison Street Sherman Oaks, CA 91403 USA
Company Description
Our mission is to facilitate and accelerate biomarker and personalized drug discovery by acknowledging the powerful role of the patient in research. We strive to develop meaningful relationships with patients that lead to empowerment and education. The Patient Portal will provide you information on how YOU can help accelerate research and treatments for your disease.
Website
http://www.sanguinebio.com
Transaction Type
Venture Equity
Transaction Amount
$5,534,250
Transaction Round
Undisclosed
Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities.
M&A Terms
Venture Investor